About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [140 citations: 1–100 of 137 articles]

Articles published in Hepatitis Research and Treatment have been cited 140 times. The following is a list of the 137 articles that have cited the articles published in Hepatitis Research and Treatment.

  • P. P. Basu, M. M. Aloysius, N. J. Shah, and R. S. Brown Jr, “Review article: the endocannabinoid system in liver disease, a potential therapeutic target,” Alimentary Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Christopher Koh, and T. Jake Liang, “What is the future of ribavirin therapy for hepatitis C?,” Antiviral Research, 2014. View at Publisher · View at Google Scholar
  • Snezana Jovanovic-Cupic, S. Glisic, M. Stanojevic, N. Vasiljevic, T. Bojic-Milinovic, A. Bozovic, and B. Dimitrijevic, “Response Factors To Pegylated Interferon-Alfa/Ribavirin Treatment In Chronic Hepatitis C Patients Genotype 1B,” Archives of Biological Sciences, vol. 66, no. 1, pp. 193–201, 2014. View at Publisher · View at Google Scholar
  • Farideh Shiva, Mansour Kamali, Fariba Shirvani, Shahnaz Armin, Roxana Ghanaiei, Sedigheh Rafiei Tabatabaie, Seyed Ali Reza Fahimzad, Ahmad Reza Shamshiri, and Abdollah Karimi, “Hand Hygiene Compliance by the Health Care Staff in a Pediatric Hospital,” Archives of Pediatric Infectious Diseases, vol. 2, no. 2, 2014. View at Publisher · View at Google Scholar
  • Arzu Oguz, Fatma Aykas, Dilek Unal, Samet Karahan, Emine Uslu, Mustafa Basak, and Ahmet Karaman, “Hepatitis B and C Seroprevalence in Solid Tumors - Necessity for Screening During Chemotherapy,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 3, pp. 1411–1414, 2014. View at Publisher · View at Google Scholar
  • S. A. Novosad, and K. L. Winthrop, “Beyond Tumor Necrosis Factor Inhibition: The Expanding Pipeline of Biologic Therapies for Inflammatory Diseases and Their Associated Infectious Sequelae,” Clinical Infectious Diseases, 2014. View at Publisher · View at Google Scholar
  • Minjie Lin, Shuiping Zhao, Li Shen, and Danyan Xu, “Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition,” Drug Safety, 2014. View at Publisher · View at Google Scholar
  • Douglas Grunwald, Darshan Kothari, and Raza Malik, “Noninvasive markers in the assessment and management of autoimmune liver diseases,” European Journal of Gastroenterology & Hepatology, vol. 26, no. 10, pp. 1065–1072, 2014. View at Publisher · View at Google Scholar
  • Ravirajsinh Jadeja, Ranjitsinh V. Devkar, and Srinivas Nammi, “Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Behzad Einollahi, Neda Raeessi, and Fereshteh Raeessi, “Can Testing for Hepatitis C Virus Core Antigen Replace the Routine Screening Assays in Patients on Hemodialysis?,” Hepatitis Monthly, vol. 14, no. 6, 2014. View at Publisher · View at Google Scholar
  • Blanca Sampedro, Candido Hernandez-Lopez, Jose Ramon Ferrandiz, Aitziber Illaro, Emilio Fabrega, Antonio Cuadrado, Paula Iruzubieta, Susana Menendez, Joaquin Cabezas, and Javier Crespo, “Computerized Physician Order Entry-Based System to Prevent HBV Reactivation in Patients Treated With Biologic Agents: The PRESCRIB Project,” Hepatology, vol. 60, no. 1, pp. 106–113, 2014. View at Publisher · View at Google Scholar
  • S. Taffon, D. Genovese, M. Blasi, P. Pierotti, A. Degli Esposti, S. Catone, P. Chionne, B. Pulimanti, A. Candido, S. Dettori, M. E. Tosti, C. Argentini, F. Mazzotta, and M. Rapicetta, “HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study,” Infection, vol. 42, no. 4, pp. 675–687, 2014. View at Publisher · View at Google Scholar
  • Beatriz Suay, and Maria Luisa Mateos-Lindemann, “Hepatitis E: An emerging disease,” Infection Genetics and Evolution, vol. 22, pp. 40–59, 2014. View at Publisher · View at Google Scholar
  • Jihang Chen, Hoi Shan Wong, Hoi Yan Leung, Pou Kuan Leong, Wing Man Chan, Na Chen, and Kam Ming Ko, “An ursolic acid-enriched extract of Cynomorium songaricum protects against carbon tetrachloride hepatotoxicity and gentamicin nephrotoxicity in rats possibly through a mitochondrial pathway: A comparison with ursolic acid,” Journal of Functional Foods, 2014. View at Publisher · View at Google Scholar
  • Linda Petrone, Teresa Chiacchio, Valentina Vanini, Elisa Petruccioli, Gilda Cuzzi, Cristina Di Giacomo, Luigia Pucci, Marzia Montalbano, Raffaella Lionetti, Angela Testa, Daniele Lapa, Assunta Navarra, and Ubaldo Visco-Comandini, “High urine IP-10 levels associate with chronic HCV infection,” Journal of Infection, vol. 68, no. 6, pp. 591–600, 2014. View at Publisher · View at Google Scholar
  • Al-Hazmi Ahmad Homoud, “Knowledge, attitudes and practice of primary healthcare physicians concerning the occupational risks of hepatitis B virus in Al Jouf Province, Saudi Arabia,” Journal of Infection and Public Health, 2014. View at Publisher · View at Google Scholar
  • N. S. Chandra, D. Ojha, S. Chatterjee, and D. Chattopadhyay, “Prevalence of hepatitis E virus infection in West Bengal, India: a hospital-based study,” Journal of Medical Microbiology, vol. 63, no. Pt_7, pp. 975–980, 2014. View at Publisher · View at Google Scholar
  • Yahia El Shazly, Khaled Hemida, Mona Rafik, Reham Al Swaff, Zainab A. Ali-Eldin, and Shaimaa GadAllah, “Detection of occult hepatitis C virus among healthy spouses of patients with HCV infection,” Journal of Medical Virology, 2014. View at Publisher · View at Google Scholar
  • Danilo Agnesod, Amedeo De Nicolo, Marco Simiele, Adnan Mohamed Abdi, Lucio Boglione, Giovanni Di Perri, and Antonio D'Avolio, “Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients,” Journal of Pharmaceutical and Biomedical Analysis, vol. 90, pp. 119–126, 2014. View at Publisher · View at Google Scholar
  • V. Padovese, A. M. Egidi, T. Fenech Melillo, B. Farrugia, P. Carabot, D. Didero, G. Costanzo, and C. Mirisola, “Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta,” Journal of Public Health, vol. 36, no. 1, pp. 22–27, 2014. View at Publisher · View at Google Scholar
  • X. Huang, and F. B. Hollinger, “Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review,” Journal of Viral Hepatitis, vol. 21, no. 3, pp. 153–162, 2014. View at Publisher · View at Google Scholar
  • Gloria Fioravanti, Hyma Polimera, Amanda Mayer, Fabio Dorville, and Eric Little, “Autoimmune Hepatitis in a 20-Year-Old African American Man,” Labmedicine, vol. 45, no. 2, pp. 161–171, 2014. View at Publisher · View at Google Scholar
  • Celina Wojciechowska, Jan Wodniecki, Romuald Wojnicz, Ewa Romuk, Wojciech Jacheć, Andrzej Tomasik, Bronisława Skrzep-Poloczek, Beata Spinczyk, and Ewa Nowalany-Kozielska, “Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients,” Mediators of Inflammation, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • S. Anitha, D. Raghunadharao, F. Waliyar, H. Sudini, M. Parveen, Ratna Rao, and P. Lava Kumar, “The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2014. View at Publisher · View at Google Scholar
  • C. Brooks Mobley, Ryan G. Toedebusch, Christopher M. Lockwood, Alexander J. Heese, Conan Zhu, Anna E. Krieger, Clayton L. Cruthirds, John C. Hofheins, Joseph M. Company, Charles E. Wiedmeyer, Dae Y. Kim, and Frank W. Booth, “Herbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-alpha expression and protein carbonylation in Western diet feeding in rats,” Nutrition & Metabolism, vol. 11, 2014. View at Publisher · View at Google Scholar
  • Sukhvinder Singh, Aman Sharma, and Sunil K. Arora, “High Producer Haplotype (CAG) of-863C/A,-308G/A and-238G/A Polymorphisms in the Promoter Region of TNF-alpha Gene Associate with Enhanced Apoptosis of Lymphocytes in HIV-1 Subtype C Infected Individuals from North India,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Masaya Sato, Mayuko Kondo, Ryosuke Tateishi, Naoto Fujiwara, Naoya Kato, Haruhiko Yoshida, Masataka Taguri, and Kazuhiko Koike, “Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Masashi Utsumi, Akinobu Takaki, Yuzo Umeda, Kazuko Koike, Stephanie C. Napier, Nobukazu Watanabe, Hiroshi Sadamori, Susumu Shinoura, Ryuichi Yoshida, Daisuke Nobuoka, Tetsuya Yasunaka, Eiichi Nakayama, Kazuhide Yamamoto, Toshiyoshi Fujiwara, and Takahito Yagi, “Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation,” Transplant Immunology, 2014. View at Publisher · View at Google Scholar
  • Patrizia Burra, Kryssia I. Rodriguez-Castro, Francesco Marchini, Luciana Bonfante, Lucrezia Furian, Alberto Ferrarese, Alberto Zanetto, Giacomo Germani, Francesco Paolo Russo, and Marco Senzolo, “Hepatitis C virus infection in end-stage renal disease and kidney transplantation,” Transplant International, vol. 27, no. 9, pp. 877–891, 2014. View at Publisher · View at Google Scholar
  • Kolakoth Pathoumthong, Phonepaseuth Khampanisong, Fabrice Quet, Vatthanaphone Latthaphasavang, Vimalay Souvong, and Yves Buisson, “Vaccination status, knowledge and awareness towards hepatitis B among students of health professions in Vientiane, Lao PDR,” Vaccine, vol. 32, no. 39, pp. 4993–4999, 2014. View at Publisher · View at Google Scholar
  • Halina Cichoz-Lach, and Agata Michalak, “Oxidative stress as a crucial factor in liver diseases,” World Journal of Gastroenterology, vol. 20, no. 25, pp. 8082–8091, 2014. View at Publisher · View at Google Scholar
  • Tao Shen, and Xin-Min Yan, “Hepatitis B virus genetic mutations and evolution in liver diseases,” World Journal of Gastroenterology, vol. 20, no. 18, pp. 5435–5441, 2014. View at Publisher · View at Google Scholar
  • Sonia Roman, Alexis Jose-Abrego, Nora Alma Fierro, Griselda Escobedo-Melendez, Claudia Ojeda-Granados, Erika Martinez-Lopez, and Arturo Panduro, “Hepatitis B virus infection in Latin America: A genomic medicine approach,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7181–7196, 2014. View at Publisher · View at Google Scholar
  • Augustine Chen, Nattanan Panjaworayan T-Thienprasert, and Chris M. Brown, “Prospects for inhibiting the post-transcriptional regulation of gene expression in hepatitis B virus,” World Journal of Gastroenterology, vol. 20, no. 25, pp. 7993–8004, 2014. View at Publisher · View at Google Scholar
  • Janaina Luz Narciso-Schiavon, and Roberto Jose de Carvalho-Filho, “Non-invasive diagnosis of liver fibrosis in chronic hepatitis C,” World Journal of Gastroenterology, vol. 20, no. 11, pp. 2854–2866, 2014. View at Publisher · View at Google Scholar
  • O. Torres, J. Matute, J. Gelineau-van Waes, J.R. Maddox, S.G. Gregory, A.E. Ashley-Koch, J.L. Showker, K.A. Voss, and R.T. Riley, “Human health implications from co-exposure to aflatoxins and fumonisins in maize-based foods in Latin America: Guatemala as a case study,” World Mycotoxin Journal, vol. 1, no. -1, pp. 1–17, 2014. View at Publisher · View at Google Scholar
  • Malihe Moradzadeh, Sirous Tayebi, Hossein Poustchi, Kourosh Sayehmiri, Parisa Shahnazari, Elnaz Naderi, Ghodratollah Montazeri, and Ashraf Mohamadkhani, “The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation,” Advances in Virology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • M. Romero-Gomez, R. Planas, J. Ampuero, R. Sola, J. Garcia-Samaniego, M. Diago, J. Crespo, J. L. Calleja, and J. Turnes, “Meta-analysis: pegylated interferon-2a achieves higher early virological responses than-2b in chronic hepatitis C,” Alimentary Pharmacology & Therapeutics, vol. 37, no. 11, pp. 1065–1073, 2013. View at Publisher · View at Google Scholar
  • Brian Bieber, Brenda Gillespie, Bruce M. Robinson, and Michel Jadoul, “Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients,” American Journal of Nephrology, vol. 38, no. 5, pp. 405–412, 2013. View at Publisher · View at Google Scholar
  • Roger Chou, and Ngoc Wasson, “Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection A Systematic Review,” Annals Of Internal Medicine, vol. 158, no. 11, pp. 807–+, 2013. View at Publisher · View at Google Scholar
  • Hai Ding, Baoming Liu, Chengyu Zhao, Jingxian Yang, Chunhui Yan, Ling Yan, Hui Zhuang, and Tong Li, “Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B,” Antiviral Research, 2013. View at Publisher · View at Google Scholar
  • Antonio D'Avolio, Amedeo De Nicolo, Jessica Cusato, Alessia Ciancio, Lucio Boglione, Silvia Strona, Giuseppe Cariti, Giulia Troshina, Gian Paolo Caviglia, Antonina Smedile, Mario Rizzetto, and Giovanni Di Perri, “Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients,” Antiviral Research, vol. 100, no. 1, pp. 114–119, 2013. View at Publisher · View at Google Scholar
  • Montserrat Maldonado-Gonzalez, Nora A. Fierro, and Sonia Roman, “Distribution of HBV genotypes F and H in Mexico and Central America,” Antiviral Therapy, vol. 18, no. 3, pp. 475–484, 2013. View at Publisher · View at Google Scholar
  • Jean Jacques N. Noubiap, Jobert Richie N. Nansseu, Karen K. Kengne, Shalom Tchokfe Ndoula, and Lucy A. Agyingi, “Occupational exposure to blood, hepatitis B vaccine knowledge and uptake among medical students in Cameroon,” Bmc Medical Education, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Maria A. Jimenez-Sousa, Amanda Fernandez-Rodriguez, Maria Guzman-Fulgencio, Monica Garcia-Alvarez, and Salvador Resino, “Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C,” Bmc Medicine, vol. 11, 2013. View at Publisher · View at Google Scholar
  • In Chul An, Ashish K. Tiwari, Srujan Ameda, and Heather S. Laird-Fick, “Autoimmune Hepatitis: Diagnostic Dilemma in the Setting of Suspected Iron Overload,” Case Reports in Gastrointestinal Medicine, vol. 2013, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Moushumi Lodh, Debkant Pradhan, and Ashok Parida, “Autoimmune Hepatitis with Anti Centromere Antibodies,” Case Reports in Immunology, vol. 2013, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Naglaa Zayed, Abu Bakr Awad, Wafaa El-Akel, Wahid Doss, Tahany Awad, Amr Radwan, and Mahasen Mabrouk, “The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C,” Clinics and Research in Hepatology and Gastroenterology, vol. 37, no. 3, pp. 254–261, 2013. View at Publisher · View at Google Scholar
  • Pietro Invernizzi, Francesca Bernuzzi, Ana Lleo, Vanila Pozzoli, Monica Bignotto, Paola Zermiani, Andrea Crosignani, Pier Maria Battezzati, Massimo Zuin, Mauro Podda, and Chiara Raggi, “Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis,” Digestive and Liver Disease, 2013. View at Publisher · View at Google Scholar
  • Niraj Kumari, Rachana Kathuria, Anshu Srivastav, Narendra Krishnani, Ujjal Poddar, and Surender K. Yachha, “Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children,” European Journal Of Gastroenterology & Hepatology, vol. 25, no. 3, pp. 333–337, 2013. View at Publisher · View at Google Scholar
  • Wei Liu, Li Wang, Yuzhang Wu, Dong Liu, Bing Ni, and Mengjun Zhang, “Hepatitis B virus core protein interacts with CD59 to promote complement-mediated liver inflammation during chronic hepatitis B virus infection,” Febs Letters, vol. 587, no. 20, pp. 3314–3320, 2013. View at Publisher · View at Google Scholar
  • Yueqiu Luo, Caixia Jin, Zongxin Ling, Xiaozhou Mou, Qiong Zhang, and Charlie Xiang, “Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF/RBV therapy using systematic meta-analysis,” Gene, vol. 513, no. 2, pp. 292–296, 2013. View at Publisher · View at Google Scholar
  • Marlin D. Friesen, Geoffroy Durand, Florence Le Calvez-Kelm, Stephanie Villar, Thiravud Khuhaprema, Suleeporn Sangrajrang, John D. Groopman, Pierre Hainaut, Amelie Chabrier, Simona Ognjanovic, Sandra Ortiz-Cuaran, and David Cox, “Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma,” Genes Chromosomes & Cancer, vol. 52, no. 10, pp. 912–919, 2013. View at Publisher · View at Google Scholar
  • Saeedeh Ravi, Hossein Khalili, Mohsen Nasiri Toosi, Iman Karimzadeh, and Mehdi Ahadi-Barzoki, “Adherence to Chronic Hepatitis C Treatment Regimen: First Report From a Referral Center in Iran,” Hepatitis Monthly, vol. 13, no. 6, 2013. View at Publisher · View at Google Scholar
  • Maryam Moini, Mazyar Ziyaeyan, Shapoor Aghaei, Mohammad Mahdi Sagheb, Seyed Alireza Taghavi, Mahsa Moeini, Marzieh Jamalidous, and Laleh Hamidpour, “Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction,” Hepatitis Monthly, vol. 13, no. 6, 2013. View at Publisher · View at Google Scholar
  • Marwa Khairy, Rabab Fouad, Mahassen Mabrouk, Wafaa El-Akel, Abu Bakr Awad, Rabab Salama, Mayada Elnegouly, and Olfat Shaker, “The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis,” Hepatitis Monthly, vol. 13, no. 6, 2013. View at Publisher · View at Google Scholar
  • Suresh D. Sharma, “Hepatitis C virus 1b viral factors (core, NS3, and NS5A) and increased risk of hepatocellular carcinoma,” Hepatology, vol. 58, no. 2, pp. 491–493, 2013. View at Publisher · View at Google Scholar
  • Yasuteru Kondo, Tomoaki Iwata, Takahiro Haga, Osamu Kimura, Masashi Ninomiya, Eiji Kakazu, Takayuki Kogure, Tatsuki Morosawa, Setsuya Aiba, and Tooru Shimosegawa, “Eradication of hepatitis C virus could improve immunological status and pyoderma gangrenosum-like lesions,” Hepatology Research, 2013. View at Publisher · View at Google Scholar
  • Haruki Komatsu, Ayano Inui, Tomoyuki Tsunoda, Tsuyoshi Sogo, and Tomoo Fujisawa, “Association between an IL-28B genetic polymorphism and the efficacy of the response-guided pegylated interferon therapy in children with chronic hepatic C infection,” Hepatology Research, vol. 43, no. 4, pp. 327–338, 2013. View at Publisher · View at Google Scholar
  • Ruijuan Zhao, Hongyan Zhou, and Shao Bo Su, “A critical role for interleukin-1β in the progression of autoimmune diseases,” International Immunopharmacology, 2013. View at Publisher · View at Google Scholar
  • Michael Eisenhut, “Neopterin in Diagnosis and Monitoring of Infectious Diseases,” Journal of Biomarkers, vol. 2013, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Yukio Osaki, and Hiroki Nishikawa, “Clinical Significance of Occult Hepatitis B Infection in Progression of Liver Disease and Carcinogenesis,” Journal Of Cancer, vol. 4, no. 6, pp. 473–480, 2013. View at Publisher · View at Google Scholar
  • B. Robert Meyer, “Autoimmune Hepatitis in Association With Ramelteon,” Journal Of Clinical Gastroenterology, vol. 47, no. 7, pp. 651–654, 2013. View at Publisher · View at Google Scholar
  • Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, and Asif Ali Burney, “Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study,” Journal of Diabetes Research, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • X. Chen, B. Dai, Z. Liu, J. Gao, Z. Ji, J. Guo, G. Chen, Z. Deng, and Z. Shao, “A novel B/C inter-genotype recombinant of hepatitis B virus identified in north-west China,” Journal of General Virology, vol. 95, no. Pt_1, pp. 153–155, 2013. View at Publisher · View at Google Scholar
  • David Semela, Andreas Geier, Johannes Schmitt, Felix Stickel, Stefan Russmann, Jean-Francois Dufour, Philip P. Becker, Darius Moradpour, Christine N. Manser, Michael T. Dill, Monika Rau, Beat Muellhaupt, and Michael Weisskopf, “Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection,” Journal Of Hepatology, vol. 58, no. 4, pp. 669–675, 2013. View at Publisher · View at Google Scholar
  • Fabio Tramuto, Carmelo M. Maida, Giuseppina M. E. Colomba, Paola Di Carlo, Giuseppe Montalto, Valentina Li Vecchi, Francesco Vitale, Giovanni Mazzola, and Mario Affronti, “Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy,” Journal Of Immigrant And Minority Health, vol. 15, no. 4, pp. 725–731, 2013. View at Publisher · View at Google Scholar
  • Christopher R. Bolen, Michael D. Robek, Leonid Brodsky, Vincent Schulz, Joseph K. Lim, Milton W. Taylor, and Steven H. Kleinstein, “The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response,” Journal of Interferon & Cytokine Research, vol. 33, no. 1, pp. 15–23, 2013. View at Publisher · View at Google Scholar
  • Daniel Candotti, Jean-Pierre Allain, and Subhajit Biswas, “Specific Amino Acid Substitutions in the S Protein Prevent Its Excretion In Vitro and May Contribute to Occult Hepatitis B Virus Infection,” Journal Of Virology, vol. 87, no. 14, pp. 7882–7892, 2013. View at Publisher · View at Google Scholar
  • Gregory Oxenkrug, “Insulin Resistance and Dysregulation of Tryptophan-Kynurenine and Kynurenine-Nicotinamide Adenine Dinucleotide Metabolic Pathways,” Molecular Neurobiology, vol. 48, no. 2, pp. 294–301, 2013. View at Publisher · View at Google Scholar
  • Noura M. Dabbouseh, and Donald M. Jensen, “Future therapies for chronic hepatitis C,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 5, pp. 268–276, 2013. View at Publisher · View at Google Scholar
  • Beth A. Conlon, Jeannette M. Beasley, Karin Aebersold, Sunil S. Jhangiani, and Judith Wylie-Rosett, “Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD),” Nutrients, vol. 5, no. 10, pp. 4093–4114, 2013. View at Publisher · View at Google Scholar
  • Krisztina Hagymási, and Zsolt Tulassay, “Autoimmun májbetegségek átfedő (overlap) szindrómáinak áttekintése. A felismerés és a kezelés nehézségei,” Orvosi Hetilap, vol. 154, no. 24, pp. 923–929, 2013. View at Publisher · View at Google Scholar
  • Yan Zhang, Lei Shan, Yaping Hua, Dan Wang, Huawu Zeng, Runhui Liu, Weidong Zhang, and Zhenlin Hu, “Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Ameliorates Concanavalin A-Induced Hepatitis in Mice,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Jonel Trebicka, Aleksander Krag, Stefan Gansweid, Peter Schiedermaier, Holger M. Strunk, Rolf Fimmers, Christian P. Strassburg, Fleming Bendtsen, Soren Moller, Tilman Sauerbruch, and Ulrich Spengler, “Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Alessandra Dicitore, Sara Castiglioni, Giovanni Vitale, Michele Caraglia, Pierosandro Tagliaferri, Alberto Abbruzzese, Monica Marra, Luca Persani, and Pasquale Sperlongano, “Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties,” Protein And Peptide Letters, vol. 20, no. 4, pp. 412–423, 2013. View at Publisher · View at Google Scholar
  • María Teresa Pérez-Gracia, María Luísa Mateos Lindemann, and María Caridad Montalvo Villalba, “Hepatitis E: current status,” Reviews in Medical Virology, 2013. View at Publisher · View at Google Scholar
  • Marcelo Zugaib, Roseli Mieko Yamamoto Nomura, Rossana Pulcineli Vieira Francisco, Roololpho Truffa Kleine, and Ana Maria Kondo Igai, “Clinical and obstetrical management of pregnant women with autoimmune hepatitis complicated by moderate or severe thrombocytopenia,” Revista Da Associacao Medica Brasileira, vol. 59, no. 1, pp. 28–34, 2013. View at Publisher · View at Google Scholar
  • A. M. Fullerton, R. A. Roth, and P. E. Ganey, “Pretreatment With TCDD Exacerbates Liver Injury From Concanavalin A: Critical Role for NK Cells,” Toxicological Sciences, 2013. View at Publisher · View at Google Scholar
  • Rachel P.L. van Swelm, Coby M.M. Laarakkers, Marisol Kooijmans-Otero, Elke M.G.J. deJong, Rosalinde Masereeuw, and Frans G.M. Russel, “Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients,” Toxicology Letters, 2013. View at Publisher · View at Google Scholar
  • Wenjuan Gao, Yuhan Sun, Shiwen Chen, Jingyao Zhang, Jingjing Kang, Yongqiang Wang, Hexiang Wang, Guoliang Xia, Qinghong Liu, and Youmin Kang, “Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and HBsAg-transgenic mice,” Vaccine, vol. 31, no. 18, pp. 2273–2280, 2013. View at Publisher · View at Google Scholar
  • Pascale Buchmann, Claudia Dembek, Larissa Kuklick, Clemens Jaeger, Raindy Tedjokusumo, Miriam John von Freyend, Uta Drebber, Zbigniew Janowicz, Karl Melber, and Ulrike Protzer, “A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice,” Vaccine, vol. 31, no. 8, pp. 1197–1203, 2013. View at Publisher · View at Google Scholar
  • Nathalia Mantovani, Maira Cicero, Luiz Claudio Santana, Carla Silveira, Eliane Pereira do Carmo, Paulo Roberto Ferreira Abrao, Ricardo Sobhie Diaz, Marcos Montani Caseiro, and Shirley Vasconcelos Komninakis, “Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and Sao Paulo, Brazil,” Virology Journal, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Domenico Capone, Giovanni Tarantino, and Carmine Finelli, “Exposure to ambient air particulate matter and non-alcoholic fatty liver disease,” World Journal Of Gastroenterology, vol. 19, no. 25, pp. 3951–3956, 2013. View at Publisher · View at Google Scholar
  • Helene Jeulin, Aurelie Velay, John Murray, and Evelyne Schvoerer, “Clinical impact of hepatitis B and C virus envelope glycoproteins,” World Journal of Gastroenterology, vol. 19, no. 5, pp. 654–664, 2013. View at Publisher · View at Google Scholar
  • Rita Rezzani, Alessandra Stacchiotti, and Luigi Fabrizio Rodella, “Morphological and biochemical studies on aging and autophagy,” Ageing Research Reviews, vol. 11, no. 1, pp. 10–31, 2012. View at Publisher · View at Google Scholar
  • Peng Cheng, You Cheng, Mei X. Su, Dong Li, Guo Z. Zhao, Hui Gao, Yan Li, Jie Y. Zhu, Hua Li, and Tao Zhang, “Bicluster and Pathway Enrichment Analysis of HCV-induced Cirrhosis and Hepatocellular Carcinoma,” Asian Pacific Journal Of Cancer Prevention, vol. 13, no. 8, pp. 3741–3745, 2012. View at Publisher · View at Google Scholar
  • Alberto R. M. Martinez, Marcelo B. Nunes, Anamarli Nucci, and Marcondes C. França, “Sensory Neuronopathy and Autoimmune Diseases,” Autoimmune Diseases, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Hind I. Fallatah, and Hisham O. Akbar, “Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview,” Autoimmune Diseases, vol. 2012, pp. 1–17, 2012. View at Publisher · View at Google Scholar
  • D. A. Gouas, S. Villar, S. Ortiz-Cuaran, P. Legros, G. Ferro, G. D. Kirk, O. A. Lesi, M. Mendy, E. Bah, M. D. Friesen, J. Groopman, I. Chemin, and P. Hainaut, “TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia,” Carcinogenesis, vol. 33, no. 6, pp. 1219–1224, 2012. View at Publisher · View at Google Scholar
  • M. Nakano, C. Saeki, H. Takahashi, S. Homma, H. Tajiri, and M. Zeniya, “Activated natural killer T cells producing interferon-gamma elicit promoting activity to murine dendritic cell-based autoimmune hepatic inflammation,” Clinical And Experimental Immunology, vol. 170, no. 3, pp. 274–282, 2012. View at Publisher · View at Google Scholar
  • Esperance A. K. Schaefer, and Daniel S. Pratt, “Autoimmune hepatitis: current challenges in diagnosis and management in a chronic progressive liver disease,” Current Opinion In Rheumatology, vol. 24, no. 1, pp. 84–89, 2012. View at Publisher · View at Google Scholar
  • A. Hashemi, F. Roohvand, M. H. Ghahremani, M. R. Aghasadeghi, R. Vahabpour, F. Motevali, and A. Memarnejadian, “Optimization of transfection methods for Huh-7 and Vero cells: A comparative study,” Cytology And Genetics, vol. 46, no. 6, pp. 347–353, 2012. View at Publisher · View at Google Scholar
  • Chih-Hung Guo, Pei-Chung Chen, Kuan-Pin Lin, Min-Yi Shih, and Wang-Sheng Ko, “Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects,” Environmental Toxicology And Pharmacology, vol. 33, no. 2, pp. 288–296, 2012. View at Publisher · View at Google Scholar
  • Antonios Katsounas, Martin Trippler, Shyam Kottilil, Richard A. Lempicki, Guido Gerken, and Joerg F. Schlaak, “Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C,” European Journal Of Medical Research, vol. 17, 2012. View at Publisher · View at Google Scholar
  • Lucyna Cova, “Progress in DNA vaccination against HBV infection,” Future Virology, vol. 7, no. 2, pp. 149–160, 2012. View at Publisher · View at Google Scholar
  • Sirous Tayebi, and Ashraf Mohamadkhani, “The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection,” Hepatitis Research and Treatment, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Jennifer Y. Chen, and Raymond T. Chung, “Future Classes of Hepatitis C Virus Therapeutic Agents,” Infectious Disease Clinics of North America, vol. 26, no. 4, pp. 949–+, 2012. View at Publisher · View at Google Scholar
  • Stephanie Dominguez, Jade Ghosn, Bruno Cassard, Giovanna Melica, Isabelle Poizot-Martin, Caroline Solas, Anne-Sophie Lascaux, Magali Bouvier-Alias, Christine Katlama, Yves Levy, and Gilles Peytavin, “Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV,” Journal Of Antimicrobial Chemotherapy, vol. 67, no. 6, pp. 1449–1452, 2012. View at Publisher · View at Google Scholar
  • Fabio Tramuto, Walter Mazzucco, Carmelo Massimo Maida, Andrea Affronti, Mario Affronti, Giuseppe Montalto, and Francesco Vitale, “Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health,” Journal Of Community Health, vol. 37, no. 3, pp. 547–553, 2012. View at Publisher · View at Google Scholar